Rosemary Harrison

Insider Reports History

Entity
Individual
Location
C/O Trillium Therapeutics Inc., 2488 Dunwin Drive, Mississauga, Ontario, Canada
Signature
/s/ Margaret Siegel as Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rosemary Harrison:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TCR2 THERAPEUTICS INC. Chief Business & Strategy Restricted Stock Unit (Right to Buy) 12.8K Dec 15, 2022 Direct
TCR2 THERAPEUTICS INC. Chief Business & Strategy Restricted Stock Unit 0 Jun 1, 2023 Direct
TCR2 THERAPEUTICS INC. Chief Business & Strategy Stock Option (Right to Buy) 0 $0.74 Jun 1, 2023 Direct
Trillium Therapeutics Inc. Title: Senior Vice President, Corporate Development and Strategy Common Shares 0 Nov 17, 2021 Direct
Trillium Therapeutics Inc. Title: Senior Vice President, Corporate Development and Strategy Stock Option (Right to Buy) 0 Nov 17, 2021 Direct

Insider Reports Filed by Rosemary Harrison

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TCRR TCR2 THERAPEUTICS INC. Jun 1, 2023 3 $0 4 Jun 1, 2023 Chief Business & Strategy
TCRR TCR2 THERAPEUTICS INC. Dec 15, 2022 2 $0 4 Dec 19, 2022 Chief Business & Strategy
TCRR TCR2 THERAPEUTICS INC. Jan 10, 2022 1 $0 4 Jan 12, 2022 Chief Business & Strategy
TCRR TCR2 THERAPEUTICS INC. Jan 10, 2022 0 $0 3 Jan 12, 2022 Chief Business & Strategy
TRIL Trillium Therapeutics Inc. Nov 17, 2021 2 $0 4 Nov 19, 2021 Title: Senior Vice President, Corporate Development and Strategy